Indication
Cryptococcal septicemia
Cryptococcal septicemia refers to a severe, life-threatening bloodstream infection and systemic dysregulated host response caused by hematogenous dissemination of encapsulated yeasts of the genus *Cryptococcus*, most commonly *Cryptococcus neoformans* or *Cryptococcus gattii*. Read more about Cryptococcal septicemia
9 drugs 9 manufacturers
Drugs that treat it
Common Cryptococcal septicemia therapies.
AMPHOTERICIN B
ABELCET (amphotericin B lipid complex)
ABELCET (amphotericin B lipid complex)
AMPHOTERICIN B LIPOSOME
AMPHOTERICIN B LIPOSOME
AMPHOTERICIN B LIPOSOME
AMPHOTERICIN B LIPOSOME
AMPHOTERICIN B LIPOSOME
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCryptococcal septicemia refers to a severe, life-threatening bloodstream infection and systemic dysregulated host response caused by hematogenous dissemination of encapsulated yeasts of the genus *Cryptococcus*, most commonly *Cryptococcus neoformans* or *Cryptococcus gattii*.
It predominantly affects individuals with severe cell-mediated immunodeficiency, particularly people living with advanced HIV disease, solid organ transplant recipients, and patients receiving systemic immunosuppressive therapy.
The condition is characterized pathophysiologically by fungemia that often originates from a primary pulmonary locus, triggering widespread vascular invasion, systemic inflammatory responses, and frequent seeding of distant organs, most notably the central nervous system.
Clinically, affected patients present with fulminant systemic signs such as persistent high fevers, hemodynamic instability, altered mental status, and progressive multi-organ dysfunction.
- cdc.gov
Cryptococcal septicemia refers to a severe, life-threatening bloodstream infection and systemic dysregulated host response caused by hematogenous dissemination of encapsulated yeasts of the genus *Cryptococcus*, most commonly *Cryptococcus neoformans* or *Cryptococcus gattii* It predominantly affects individuals with severe cell-mediated immunodeficiency, particularly people living with advanced HIV disease, solid organ transplant recipients, and patients receiving systemic immunosuppressive the...
- nih.gov
Cryptococcal septicemia refers to a severe, life-threatening bloodstream infection and systemic dysregulated host response caused by hematogenous dissemination of encapsulated yeasts of the genus *Cryptococcus*, most commonly *Cryptococcus neoformans* or *Cryptococcus gattii* The condition is characterized pathophysiologically by fungemia that often originates from a primary pulmonary locus, triggering widespread vascular invasion, systemic inflammatory responses, and frequent seeding of distant...
- merckmanuals.com
Cryptococcal septicemia refers to a severe, life-threatening bloodstream infection and systemic dysregulated host response caused by hematogenous dissemination of encapsulated yeasts of the genus *Cryptococcus*, most commonly *Cryptococcus neoformans* or *Cryptococcus gattii* It predominantly affects individuals with severe cell-mediated immunodeficiency, particularly people living with advanced HIV disease, solid organ transplant recipients, and patients receiving systemic immunosuppressive the...
- oup.com
Clinically, affected patients present with fulminant systemic signs such as persistent high fevers, hemodynamic instability, altered mental status, and progressive multi-organ dysfunction
Personalize your experience
Follow Cryptococcal septicemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.